pEN_TT 3xFLAG LacZ
(Plasmid
#83093)
-
PurposeGateway entry vector for inducible expression of LacZ with N-terminal 3xFLAG tag
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 83093 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEN_TTmiRc2
-
Backbone manufacturerAddgene #83274
- Backbone size w/o insert (bp) 4422
-
Modifications to backbone3xFLAG cloned in frame before restriction sites
-
Vector typeentry vector for gateway cloning
Growth in Bacteria
-
Bacterial Resistance(s)Gentamicin, 10 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Growth instructionsDB3.1 (ccdB survival)
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameLacZ
-
Insert Size (bp)3045
- Promoter TRE tight promoter
-
Tag
/ Fusion Protein
- 3xFLAG (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SpeI (unknown if destroyed)
- 3′ cloning site MfeI (unknown if destroyed)
- 5′ sequencing primer pCEP-fwd (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byPCR cloned from Addgene #25893
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Gateway entry vector for expression of 3xFLAG LacZ
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pEN_TT 3xFLAG LacZ was a gift from Kevin Janes (Addgene plasmid # 83093 ; http://n2t.net/addgene:83093 ; RRID:Addgene_83093) -
For your References section:
Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer. Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA, Janes KA. Dev Cell. 2017 Nov 20;43(4):418-435.e13. doi: 10.1016/j.devcel.2017.10.027. 10.1016/j.devcel.2017.10.027 PubMed 29161592